Furthermore, B2M in GSCs could activate the PI3K/AKT/MYC signaling axis to stimulate TGF-β1 secretion, thereby induced AKT pathway activation in macrophages to promote their polarization into M2 types, which, in turn, facilitated glioma progression (Li et al. 2022). The gene discussed is B2M; the disease is central nervous system cancer.